Regeneron Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
REGN Regeneron Pharmaceuticals Inc
BRTR Barrister Global Services Network Inc
EBTC Enterprise Bancorp Inc
FSLY Fastly Inc
BNR Burning Rock Biotech Ltd
FCNKX Fidelity® Contrafund® Fund Class K
CAT Caterpillar Inc
POAGX PRIMECAP Odyssey Aggressive Growth Fund
VFIFX Vanguard Target Retirement 2050 Fund Investor Shares
CMCSA Comcast Corp
Go

Health Care : Biotechnology | Large Cap Growth
Company profile

Regeneron Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, invents, develops, manufactures and commercializes medicines for the treatment of serious medical conditions. The Company commercializes medicines for eye diseases, high low-density lipoprotein (LDL) cholesterol, and an inflammatory condition and have product candidates in development in other areas, including rheumatoid arthritis, asthma, atopic dermatitis, pain, cancer, and infectious diseases. The Company's marketed products include EYLEA (aflibercept) Injection, Praluent (alirocumab) Injection, ARCALYST (rilonacept) Injection for Subcutaneous Use, Kevzara (sarilumab) Solution for Subcutaneous Injection and ZALTRAP (ziv-aflibercept) Injection for Intravenous Infusion. As of December 31, 2016, the Company had 16 product candidates in clinical development, which consisted of a Trap-based clinical program and 15 fully human monoclonal antibody product candidates.

Closing Price
$610.89
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
0

10-day average volume:
627,317
0
  • Prev Close
    610.89
  • Today's Open
    --
  • Day's Range
    --
  • Avg Vol (10-day)
    627.3K
  • Last (time)
    3:59p ET 08/13/20
  • Last (size)
    1
  • 52-Wk Range
    271.37 - 664.64
    LowHigh
  • (09/27/19 - 07/20/20)
    8.09%
  • 40.6%
  • Market Cap
    65.0B
  • Shares Outstanding
    106.4M
  • 25.83
  • 23.65x
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 0.5
  • 74.32
  • (% of float 07/31/20)
    1.94

Latest News

August 12, 2020
7:00 am ET
PR Newswire
August 07, 2020
4:05 pm ET
PR Newswire
August 05, 2020
6:59 am ET
MarketWatch
6:43 am ET
MarketWatch
6:41 am ET
MarketWatch
6:40 am ET
MarketWatch
6:40 am ET
MarketWatch
6:40 am ET
MarketWatch
August 03, 2020
9:38 am ET
PR Newswire
8:30 am ET
BusinessWire
July 29, 2020
10:25 pm ET
PR Newswire
9:00 pm ET
PR Newswire
7:24 am ET
MarketWatch
7:00 am ET
PR Newswire
July 23, 2020
11:54 am ET
PR Newswire
July 22, 2020
8:20 pm ET
PR Newswire
July 20, 2020
10:00 am ET
Globe Newswire
July 09, 2020
9:41 am ET
MarketWatch
8:21 am ET
MarketWatch
8:21 am ET
MarketWatch
July 08, 2020
4:30 pm ET
PR Newswire
July 07, 2020
9:00 am ET
PR Newswire
7:22 am ET
MarketWatch
7:04 am ET
MarketWatch
7:03 am ET
MarketWatch
7:00 am ET
PR Newswire
July 06, 2020
3:12 pm ET
MarketWatch
7:26 am ET
MarketWatch
7:05 am ET
MarketWatch
7:00 am ET
PR Newswire
July 02, 2020
10:47 pm ET
PR Newswire
4:59 pm ET
MarketWatch
4:29 pm ET
PR Newswire
July 01, 2020
11:28 am ET
Globe Newswire
June 24, 2020
3:23 pm ET
PR Newswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.